When Should You Worry About an Adnexal Cyst?

Most adnexal cysts are benign and never require treatment. These fluid-filled sacs, found on or near the ovaries, turn up on routine imaging so often that radiologists have developed formal scoring systems just to keep clinicians from over-reacting to harmless findings. That said, certain features on ultrasound, certain blood markers, and certain patient profiles genuinely do raise a red flag. Knowing which signals matter and which you can safely ignore makes the difference between appropriate watchfulness and unnecessary anxiety or surgery.

The Cysts That Almost Always Resolve on Their Own

Functional ovarian cysts are by far the most common type of adnexal cyst in people who are still menstruating. They form as a normal part of the ovulatory cycle: either a follicle fails to release its egg and keeps growing, or the corpus luteum that forms after ovulation fills with fluid or blood. A prospective trial found that about three-quarters of functional cysts resolved completely with no treatment at all, and the ones that persisted after one cycle disappeared after a second period of watchful waiting.¹ Oral contraceptives did not speed up resolution in that trial, which matches the broader evidence that birth-control pills prevent new functional cysts but do not shrink existing ones.

In younger patients, including adolescents, cysts with complex-looking ultrasound features still frequently resolve. A large imaging follow-up study found that about 60% of ovarian cysts in the preadolescent and adolescent population had non-simple characteristics (internal echoes, thin septations, or debris), yet the average time to documented resolution was around six months.² The takeaway: a cyst that looks a little messy on the screen in a young person is not automatically worrisome. Repeat imaging in a few months is usually all that’s needed.

Features That Should Raise Concern on Ultrasound

Ultrasound is the first-line tool for evaluating any adnexal mass. What the sonographer looks for is not just size but internal architecture. A truly simple cyst is a thin-walled, fluid-filled structure with no solid areas, no thick septations, and no internal blood flow on Doppler. That profile carries an extremely low risk of malignancy regardless of your age. Simple ovarian cysts found incidentally in postmenopausal women frequently resolve on their own or persist without ever progressing, and they do not appear to raise the risk of developing invasive ovarian cancer.³

The features that push a cyst into worrisome territory include solid components inside or along the wall, thick or irregular septations (the dividers within a multi-chambered cyst), papillary projections that stick out into the fluid, and significant internal blood flow detected on color Doppler. Large size alone is not the strongest predictor of cancer, but it adds to the overall risk picture, especially in combination with solid elements.

To standardize the way clinicians talk about these findings, the American College of Radiology developed the O-RADS ultrasound scoring system. It assigns each adnexal mass a risk category from 0 to 5, with a specific management recommendation for each tier, the goal being to eliminate vague language like “indeterminate” or “cannot exclude malignancy” from radiology reports.⁴ If your ultrasound report mentions an O-RADS score of 2 or 3, your clinician is likely to recommend repeat imaging. Scores of 4 or 5 typically prompt referral to a gynecologic oncologist or at least a more advanced workup.

A parallel system called the IOTA simple rules uses a set of benign features (B-rules) and malignant features (M-rules) to classify masses. When the rules apply cleanly, they achieve sensitivity above 90% and specificity in the high 80s to low 90s for distinguishing benign from malignant masses.^{5 6} A head-to-head comparison of IOTA simple rules, O-RADS, and the blood marker CA-125 found that IOTA and O-RADS both achieved over 94% sensitivity for detecting malignancy, outperforming CA-125 alone.⁷ The practical message: if your ultrasound report uses one of these scoring systems and the mass is classified as likely benign, the accuracy backing that classification is solid.

How Age and Menopause Change the Risk Equation

Your age and whether you have gone through menopause matter a great deal. In premenopausal women, the rate of malignancy among adnexal masses runs around 8%, while in postmenopausal women that figure jumps to roughly 38%.⁸ That statistic is not as alarming as it sounds, because it comes from surgical series where the masses were already suspicious enough to operate on. Among incidentally found simple cysts in postmenopausal women, malignancy is rare. In one series of 500 simple postmenopausal cysts followed conservatively, more than half resolved on their own and only four turned out to be malignant or borderline.⁹ Another study confirmed that simple cysts during menopause carry a low risk of malignant transformation and can generally be followed conservatively, since the majority either resolve or persist unchanged.¹⁰

The picture changes when the cyst is complex. A study of postmenopausal women with complex adnexal masses found that even when the blood marker CA-125 came back normal, the malignancy risk was about 9%.¹¹ That is high enough to warrant referral rather than simple surveillance. The lesson is that in postmenopausal women, a normal CA-125 level does not fully reassure you if the imaging itself looks complex.

What Blood Tests Can and Cannot Tell You

CA-125 is the most widely used blood marker for evaluating ovarian masses, but it has real limitations. It can be elevated by endometriosis, fibroids, pelvic inflammatory disease, liver disease, and even early pregnancy, which means false positives are common, especially in premenopausal women. One multicenter trial reported that CA-125 achieved 96% sensitivity in premenopausal women but only 60% specificity, meaning it flagged a lot of benign cysts as suspicious.¹² In postmenopausal women, its specificity improves to about 80%, which is better but still imperfect.

A newer marker called HE4 tends to have the opposite profile: lower sensitivity but higher specificity, meaning it misses more cancers but produces fewer false alarms. In one analysis, HE4 had a specificity of nearly 98% compared to 46% for CA-125 in women with nonfunctional ovarian cysts, though its sensitivity was considerably lower.¹³ Clinicians often combine CA-125 and HE4 into a formula called ROMA (Risk of Ovarian Malignancy Algorithm), which generally outperforms either marker used alone. When at least one of the two markers was positive, the negative predictive value reached about 92%, meaning a double-negative result was quite reassuring for ruling out malignancy.¹⁴

One important caveat: CA-125 has a notably high false-positive rate in women with endometriomas (about 45% of endometrioma patients in one study had elevated CA-125 without malignancy), so that marker is especially unreliable in the setting of known endometriosis.¹⁴

Endometriomas Deserve Their Own Conversation

Endometriomas, sometimes called “chocolate cysts” because of the thick brown fluid they contain, develop when endometrial tissue grows on the ovary. They are common in people with endometriosis, and while the vast majority remain benign, they carry a modestly elevated risk of transformation into certain ovarian cancers. The risk is estimated at roughly two to three times that of the general population, and the cancers that arise tend to be clear-cell or endometrioid subtypes.¹⁵

A case-control study identified specific risk factors for endometrioma-associated cancer. Age 42 or older, menopause, unexplained weight loss, cyst diameter above about 8 cm, and the presence of a solid area on ultrasound all independently raised the odds. Of those factors, menopause and large cyst diameter carried the highest odds ratios.¹⁶ A separate clinical series found that the average age at malignant transformation was about 45 years, with a long latency from initial endometrioma diagnosis to cancer development, averaging around four and a half years overall. Patients over 45 had shorter latency intervals (around one year on average) compared to younger patients (around eight years).¹⁷

If you have a known endometrioma, the development of a new solid component, rapid growth, or unexpected symptoms like weight loss should prompt re-evaluation rather than continued observation alone.

Dermoid Cysts and Other Persistent Types

Dermoid cysts (mature cystic teratomas) are a common benign tumor, especially in younger women. They contain an eclectic mix of tissue types and tend not to resolve on their own. When removed surgically via cystectomy, the recurrence rate is about 3–4%, and malignant transformation is estimated at well under 2%.¹⁸ Malignant transformation in a dermoid, when it does occur, almost always happens in women over 40 and is most commonly squamous cell carcinoma arising from the cyst lining. A dermoid found incidentally in a younger patient, especially if it is small and stable, can often be monitored with periodic ultrasound rather than immediately removed.

It is also worth knowing that not every adnexal cyst comes from the ovary. Paraovarian and paratubal cysts arise from remnant tissue near the fallopian tube. On ultrasound, they can be indistinguishable from ovarian cysts unless the sonographer recognizes that the cyst is separate from the ovary, often identified by sliding the ultrasound probe between the cyst and the ovary (the “split sign”).¹⁹ These non-ovarian cysts are almost always benign. Borderline or malignant paratubal tumors exist but are extremely rare.²⁰

When a Cyst Becomes an Emergency

The scenarios that send you to the emergency room are not about cancer risk but about acute complications: torsion and rupture.

Ovarian torsion happens when a cyst or enlarged ovary twists on its stalk, cutting off its blood supply. The symptoms are sudden, severe pelvic pain, often with nausea and vomiting. Ultrasound with color Doppler can help identify torsion, but a normal Doppler result does not rule it out, so diagnosis still relies heavily on clinical suspicion.²¹ The standard treatment is emergency surgery to untwist (detorse) the ovary, and even when the ovary appears dark and damaged, surgeons now favor preserving it rather than removing it, because follow-up studies show high rates of functional recovery after detorsion.

Cyst rupture can cause sharp pain and internal bleeding. The good news is that most ruptured cysts, including hemorrhagic corpus luteum cysts, can be managed without surgery. In one series, about 81% of women with a ruptured cyst and confirmed internal bleeding were treated conservatively with pain management, fluids, and monitoring.²² Surgery was needed in roughly one in five patients, and the strongest predictors of needing an operation were low diastolic blood pressure and a large amount of free fluid in the pelvis on imaging. A hemorrhagic corpus luteum that causes peritoneal irritation can often be managed with a wait-and-see approach using pain relief, fluids, and close monitoring.²³

The bottom-line rule for emergencies: sudden, severe, one-sided pelvic pain warrants urgent evaluation regardless of whether you have a known cyst.

Adnexal Cysts Found During Pregnancy

Adnexal masses are discovered in a significant number of pregnancies, largely because routine prenatal ultrasound catches things that would otherwise go unnoticed. Most are benign and incidental, and many resolve on their own, particularly corpus luteum cysts from early pregnancy.²⁴ The challenge is that tumor markers like CA-125 are unreliable in pregnancy because normal pregnancy physiology can alter their levels, making interpretation difficult.

Management decisions during pregnancy hinge on the cyst’s appearance, its size, whether it’s causing symptoms, and the gestational age. Surgery is generally avoided in the first trimester when possible, with the second trimester considered the safest window if an operation is needed. Laparoscopy is preferred over open surgery due to faster recovery and lower blood-clot risk.²⁵ A cyst that is clearly simple and stable on serial imaging can usually be watched through delivery. One that has worrisome imaging features or is large enough to obstruct labor may need intervention timed carefully around the pregnancy.²⁶

When Surgery Is Recommended and What Kind

For a cyst that is clearly benign, the goal of surgery is to remove the cyst while saving as much healthy ovarian tissue as possible. Cystectomy (shelling out the cyst) preserves the ovary, while salpingo-oophorectomy removes the entire ovary and fallopian tube. For borderline ovarian tumors, which sit in a gray zone between clearly benign and clearly malignant, the surgical choice has real consequences.

A meta-analysis comparing the two approaches in borderline tumors found that cystectomy carried about twice the risk of recurrence compared to salpingo-oophorectomy. However, the pregnancy rates after the two procedures were similar, meaning the more conservative surgery did not give a fertility advantage despite preserving ovarian tissue.²⁷ A long-term follow-up study over 24 years found that roughly one in four women treated conservatively for borderline tumors developed a local recurrence, though the recurrence rate was not statistically different between the cystectomy and salpingo-oophorectomy groups in that particular series.²⁸ The overall message: borderline tumors recur at meaningful rates regardless of surgical approach, so long-term follow-up is essential no matter what procedure is chosen.

When Ultrasound Isn’t Enough

Sometimes an ultrasound cannot definitively classify a cyst, and MRI is the next step. MRI excels at distinguishing different tissue types and is particularly useful for masses that score in the “indeterminate” range on ultrasound-based systems. Adding specialized MRI techniques like diffusion-weighted imaging (DWI) can improve diagnostic accuracy further. One study found that quantitative DWI significantly improved the ability to tell malignant from benign lesions, especially in the tricky O-RADS MRI score 4 subgroup where the ultrasound had already flagged concern without providing a clear answer.²⁹ Another study confirmed that adding diffusion-weighted and contrast-enhanced sequences to standard MRI provided additional characterization of complex masses.³⁰

In practice, MRI is not needed for every adnexal cyst. It is reserved for cases where the ultrasound is inconclusive, where the stakes are high (such as deciding whether to proceed with surgery in a young patient who wants to preserve fertility), or where the clinical picture doesn’t match the imaging.

The Anxiety Factor Is Real

One dimension that often gets overlooked in clinical discussions is the psychological toll of being told you have “a cyst on your ovary.” Many people immediately assume cyst means cancer, which is understandable given the cultural weight of that word. But as the updated consensus from the Society of Radiologists in Ultrasound emphasized, simple adnexal cysts carry such a low risk that streamlined follow-up protocols, including less frequent imaging and clearer reporting language, benefit patients by reducing unnecessary anxiety and surgery for benign findings.³¹ If your report describes a simple cyst and your clinician recommends monitoring rather than surgery, that recommendation reflects solid evidence, not a missed diagnosis.

Where Ovarian Cancer Actually Begins

Recent research has shifted the understanding of where the most common and deadliest form of ovarian cancer, high-grade serous carcinoma, actually originates. Rather than arising in the ovary itself, accumulating evidence points to the fallopian tube, specifically the fimbriated end closest to the ovary, as the starting point. Precursor lesions called serous tubal intraepithelial carcinomas have been identified in the fallopian tubes of women who went on to develop high-grade serous ovarian cancer.³² Proteomic studies have confirmed the fimbrial origin of these tumors at the molecular level.³³

Mathematical models suggest that decades may pass between the earliest molecular change (a TP53 mutation) and the development of a visible precursor lesion, followed by a shorter window of roughly six years before progression to invasive cancer.³⁴ This understanding has practical implications: it is why some gynecologists now recommend removing the fallopian tubes (salpingectomy) at the time of any pelvic surgery in women who have completed childbearing, even if the ovaries are left in place. It also explains why a simple ovarian cyst, which sits on a completely different biological pathway, is not meaningfully “on its way” to becoming high-grade serous cancer. The dangerous cancer tends not to start as a cyst you can see on ultrasound. The cysts you can see are, overwhelmingly, something else entirely.